FIGIJ and NASPAG Advocacy Statement Supporting Fertility Preservation for Pediatric and Adolescent Patients Receiving Gonadotoxic Therapy

J Pediatr Adolesc Gynecol. 2024 Oct;37(5):457-459. doi: 10.1016/j.jpag.2024.06.001. Epub 2024 Jun 14.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Adolescent
  • Antineoplastic Agents / adverse effects
  • Child
  • Female
  • Fertility Preservation* / methods
  • Humans
  • Neoplasms / drug therapy
  • Patient Advocacy

Substances

  • Antineoplastic Agents